Nectar Lifesciences Limited

NSE: NECLIFE BSE: 532649 SECTOR: Healthcare - Pharmaceuticals & Biotechnology

14 1(-5%)

Volume

Open

High

Low

VWAP

52 Week High

52 Week Low

Viand Research Rating

Quality Score

00/00

Growth Score

00/00

Valuation Score

00/00

Momentum Score

00/00

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

265

No. of Shares

19.4

P/E

70.39

P/B

0.71

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

ROCE

Profit Growth

Listing Date

18-Jul-05

Promoter Holding

51.84%

FII Holding

0.58%

DII Holding

Price Chart

Price Performance

1 Week0

1 Month0

3 Months0

6 Months0

1 Year0

YTD0

Moving Average

5 Day SMA0

10 Day SMA0

20 Day SMA0

30 Day SMA0

50 Day SMA0

61 Day SMA0

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3
Resistance 2
Resistance 1
Pivot Point
Support 1
Support 2
Support 3

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	Div Yld %
1	SUNPHARMA	4,42,187	1843	2%	14%	2%	9%	39	0	0	0
2	DIVISLAB	1,80,280	6791	2%	6%	4%	1%	65	0	0	0
3	TORNTPHARM	1,53,281	4529	0%	8%	18%	40%	64	0	0	0
4	APOLLOHOSP	1,19,047	8280	3%	7%	12%	17%	58	0	0	0
5	CIPLA	1,14,869	1422	1%	10%	7%	4%	22	0	0	0
6	DRREDDY	1,11,015	1330	0%	1%	7%	7%	20	0	0	0
7	ZYDUSLIFE	1,09,378	1087	6%	16%	15%	17%	20	0	0	0
8	LUPIN	1,04,017	2275	1%	2%	9%	15%	23	0	0	0
9	MANKIND	1,00,482	2434	3%	7%	7%	2%	49	0	0	0
10	MAXHEALTH	96,867	995	7%	1%	15%	14%	0	0	0	0
Load More

Shareholding Pattern (%)

	Jan 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021
Promoters	(6.91) 51.84%	(0.01) 44.91%	(0.41) 44.91%	(0.01) 44.53%	(0.01) 44.53%	(-11.31) 44.53%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%	(0.01) 55.80%
FIIs	(0.11) 0.58%	(-0.11) 0.52%	(-0.21) 0.62%	(-0.81) 0.82%	(0.91) 1.65%	(-2.51) 0.73%	(-13.41) 3.24%	(-0.41) 16.60%	(0.91) 16.98%	(0.11) 16.12%	(0.01) 16.02%	(-0.11) 16.00%	(0.11) 16.07%	(-0.11) 15.99%	(14.61) 16.12%	(-0.21) 1.49%	(0.21) 1.67%	(-0.91) 1.52%	(0.01) 2.46%
DIIs	(0.01) 0.00%	(-0.11) 0.00%	(-0.11) 0.08%	(0.01) 0.19%	(0.21) 0.15%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%	(0.01) 0.00%
Government	3.56%	5.84%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.02%	0.00%	0.00%	0.00%	0.00%
Public	44.02%	48.73%	54.37%	54.45%	53.64%	54.72%	40.94%	27.57%	27.20%	28.05%	28.17%	28.18%	28.12%	28.20%	28.06%	42.72%	42.53%	42.68%	41.74%
No. of Shareholders	76,648	78,124	76,470	71,977	69,241	69,482	66,741	58,230	59,946	60,761	60,283	61,582	62,874	64,422	62,940	63,909	64,012	56,073	55,124

Quarterly Results

	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021	Sep 2021	Jun 2021
Sales	0	1	5	431	0	6	359	441	452	398	394	389	344	389	403	476	443.01	364.57	385.06
Expenses	2	0	6	585	0	6	319	393	410	371	359	371	343	396	361	427	396.43	337.11	349.69
Operating Profit	-2	1	-1	-154	0	-1	40	48	42	27	36	18	1	-7	42	49	46.58	27.46	35.37
OPM %	0	77	-16	-36	-500	-10	11	11	9	7	9	5	0	-2	10	10	10.51	7.53	9.19
Other Income	35	-176	-62	0	8	7	1	1	0	11	0	18	13	11	0	1	0.53	5.1	5.15
Interest	30	0	0	18	0	0	20	24	25	21	18	20	17	21	21	17	17.62	18.01	25.75
Depreciation	0	0	1	16	0	0	15	15	15	15	15	15	15	15	15	14	14.28	14.15	14.28
Profit before tax	3	-176	-64	-188	8	5	5	11	2	2	3	2	-18	-32	6	18	15.21	0.4	0.49
Tax %	-339	0	-1	-31	2	-2	40	95	36	38	41	-145	-47	-31	36	35	36.09	-367.5	-265.31
Net Profit	14	-176	-63	-130	8	6	3	1	2	1	2	4	-9	-22	4	12	9.73	1.86	1.79
EPS in Rs	0.64	-7.85	-2.82	-5.8	0.35	0.25	0.13	0.03	0.07	0.05	0.08	0.16	-0.41	-1	0.17	0.52	0.43	0.08	0.08

Profit and Loss

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Sales	1664	1682	1520	1665	1541	2363	2779	1874	1635	1674	1638	1634	1622
Expenses	1694	1530	1467	1507	1432	2143	2514	1638	1411	1436	1371	1345	1332
Operating Profit	-30	152	53	159	109	220	264	236	224	239	267	289	290
OPM %	-2	9	3	10	7	9	10	13	14	14	16	18	18
Other Income	5	15	43	11	-22	4	6	6	23	6	20	12	16
Interest	75	87	79	79	112	126	148	115	117	123	126	138	115
Depreciation	62	61	59	57	60	61	63	64	62	57	77	84	76
Profit before tax	-162	18	-42	34	-85	37	59	63	67	64	85	78	115
Tax %	-30	73	-43	26	-14	15	19	17	18	15	22	21	25
Net Profit	-114	5	-24	25	-73	32	48	52	55	54	66	62	86
EPS in Rs	-5.07	0.22	-1.08	1.12	-3.27	1.42	2.12	2.33	2.47	2.42	2.95	2.77	3.82
Dividend Payout %	0	0	0	0	0	4	2	2	2	4	3	4	3

Cash Flows

	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Cash from Operating Activity	169	225	134	95	21	285	239	65	199	169	144	255	361
Cash from Investing Activity	-42	-17	52	17	-29	-33	-26	-29	-18	-77	-60	-90	-99
Cash from Financing Activity	-128	-205	-186	-119	11	-252	-201	-40	-204	-89	-61	-161	-282
Net Cash Flow	-1	2	0	-8	4	0	12	-4	-23	3	23	4	-20

Balance Sheet

	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014	Mar 2013
Equity Capital	22	22	22	22	22	22	22	22	22	22	22	22	22	22	22
Reserves	694	934	1055	1047	1042	1065	1040	1114	1083	1036	984	932	936	905	845
Borrowings	459	582	629	636	754	860	903	779	903	955	878	962	925	858	879
Other Liabilities	639	509	476	486	371	443	423	718	696	710	696	640	628	609	527
Total Liabilities	1815	2047	2183	2191	2189	2391	2388	2633	2705	2724	2581	2556	2510	2394	2274
Fixed Assets	28	633	804	643	662	723	772	785	825	852	881	906	934	948	914
CWIP	0	57	57	66	78	85	99	115	100	100	102	99	91	122	139
Investments	1	1	1	1	1	1	1	0	1	1	1	1	1	0	0
Other Assets	1786	1357	1321	1482	1449	1582	1517	1733	1780	1771	1597	1551	1485	1324	1221
Total Assets	1815	2047	2183	2191	2189	2391	2388	2633	2705	2724	2581	2556	2510	2394	2274

Delivery

#	Date	9 60% 15	Value (Cr)	Q/T 571	Del 65	Del 1
1	11-May	14	1	339	70	1
2	8-May	14	3	690	64	2
3	7-May	14	1	621	85	1
4	6-May	12	0	298	69	0
5	5-May	12	0	197	73	0
6	4-May	12	0	257	56	0
7	30-Apr	12	0	254	64	0
8	29-Apr	13	0	256	67	0
9	28-Apr	12	1	358	60	0
10	27-Apr	13	0	340	71	0
11	24-Apr	12	0	393	68	0
12	23-Apr	12	1	369	49	0
13	22-Apr	12	0	321	66	0
14	21-Apr	12	0	277	59	0
15	20-Apr	12	0	378	76	0
16	17-Apr	13	1	394	50	0
17	16-Apr	12	1	497	48	0
18	15-Apr	12	1	475	68	0
19	13-Apr	12	1	526	40	1
20	10-Apr	12	1	945	67	0
21	9-Apr	11	1	470	62	0
22	8-Apr	11	1	564	68	1
23	7-Apr	10	0	546	79	0
24	6-Apr	10	1	551	73	0
25	2-Apr	10	1	471	68	0
26	1-Apr	10	0	764	91	0
27	30-Mar	9	0	512	62	0
28	27-Mar	10	1	627	78	1
29	25-Mar	10	1	580	70	0
30	24-Mar	10	0	455	62	0
31	23-Mar	10	1	581	76	0
32	20-Mar	11	0	356	68	0

Daily Market Cap

Date	Total Market Cap	Change	Chg %
11-May	265c	2c	0.59
07-May	263c	23c	9.53
06-May	241c	2c	0.98
05-May	238c	4c	1.68
04-May	242c	2c	0.97
30-Apr	240c	4c	1.59
29-Apr	244c	1c	0.48
28-Apr	245c	15c	6.50
24-Apr	230c	8c	3.43
23-Apr	238c	2c	0.73
22-Apr	240c	5c	1.98
21-Apr	235c	15c	5.98
17-Apr	250c	13c	5.31
16-Apr	238c	2c	0.81
15-Apr	240c	0	0

Stock Checklist

Price is below from 52 week high low average: 54%

Stock is trading above all short term SMAs: NO

Stock is trading above all long term SMAs: NO

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: YES

Promoters are buying the stock: YES

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements

Corporate Announcements

NseIndia | Trendlyne | Screener | TradingView